Chuangui Song

5PUBLICATIONS
22CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 03, 2026
Spatial habitat radiomics predicts tertiary lymphoid structure status and identifies an IDO1+ migratory dendritic cell axis in breast cancer.

|Feb 16, 2026
PET/CT-based quantification of intratumoral heterogeneity for predicting pathological complete response in breast cancer patients treated with neoadjuvant chemotherapy: A multicentre study.

Jiwen Zhang, Xin Yu, Xiaofen Li

|Oct 24, 2025
TM9SF1 drives the lipophagic flux via AMPK-ULK1 signaling to sustain metabolic fitness in HER2-positive breast cancer.

Xiaofen Li, Xiaoqin Yu, Kaiyan Huang

|Apr 04, 2025
Safety and Efficacy of KN046 in Combination with KN026 in Patients with Advanced HER2-Positive Breast Cancer: A Phase II Trial.

Jieqiong Liu, Chuangui Song, Yaping Yang

|Dec 10, 2024
Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer.

Qing Wang, Yushuai Yu, Chenxi Wang

Pageof 1

Frequent Collaborators

1 joint publications

Zhenhui Li

1 joint publications

Shicong Tang

1 joint publications

Jieqiong Liu

1 joint publications

Yaping Yang